| 查看: 1007 | 回复: 6 | |||
| 当前主题已经存档。 | |||
[交流]
【求助】扎那米韦的分析
|
|||
|
哪位虫友做过扎那米韦这种药物分析的请不吝赐教!!! 主要包括以下两个方面:比旋度,HPLC分析中可能存在的杂质.谢谢. [ Last edited by 笨笨猪0608 on 2009-9-30 at 08:10 ] |
回复此楼» 猜你喜欢
纳米传感器监测农药残留的疑惑
已经有0人回复
-
谁有人卫版 《毒理学基础》第七版书籍
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有109人回复
-
关于SCI杂志发表挂名
已经有32人回复
-
26有没有老师想收做定量药理的学生啊
已经有3人回复
-
26考博申请 学or专
已经有15人回复
-
NSCLC脑转移肿瘤模型
已经有0人回复
-
CHP-134这个细胞系哪里有？
已经有0人回复
-
看过往病历，有疑惑请教
已经有1人回复
montclimber
金虫 (正式写手)
- 应助: 0 (幼儿园)
- 金币: 516.8
- 帖子: 359
- 在线: 31.2小时
- 虫号: 469926
- 注册: 2007-11-29
- 性别: MM
- 专业: 合成药物化学
2楼2009-10-03 20:43:09
zqwxling
木虫 (著名写手)
- 应助: 0 (幼儿园)
- 金币: 2015.5
- 散金: 670
- 帖子: 1446
- 在线: 15.7小时
- 虫号: 830506
- 注册: 2009-08-19
- 专业: 有机分析
3楼2009-10-04 08:20:54
zhongweixu
铁杆木虫 (著名写手)
- 应助: 1 (幼儿园)
- 金币: 6124.4
- 散金: 7
- 帖子: 1128
- 在线: 30.4小时
- 虫号: 857670
- 注册: 2009-09-27
- 专业: 色谱分析
4楼2009-10-10 15:20:59
5楼2009-10-12 12:41:36
zmkj
木虫 (正式写手)
- 应助: 2 (幼儿园)
- 金币: 3264.5
- 散金: 1
- 红花: 3
- 帖子: 340
- 在线: 144.3小时
- 虫号: 855405
- 注册: 2009-09-24
- 专业: 药物化学
扎那米韦
★
wang3shi(金币+1):谢谢参与
wang3shi(金币+1):谢谢参与
|
Identifiers CAS number 139110-80-8 ATC code J05AH01 PubChem 60855 DrugBank APRD00378 Chemical data Formula C12H20N4O7 Mol. mass 332.31 g/mol Synonyms 5-acetamido- 4-guanidino- 6-(1,2,3-trihydroxypropyl)- 5,6-dihydro- 4H-pyran- 2-carboxylic acid Pharmacokinetic data Bioavailability 2% (oral) Protein binding <10% Metabolism Negligible Half life 2.5–5.1 hours Excretion Renal |
6楼2009-12-08 15:51:59
zmkj
木虫 (正式写手)
- 应助: 2 (幼儿园)
- 金币: 3264.5
- 散金: 1
- 红花: 3
- 帖子: 340
- 在线: 144.3小时
- 虫号: 855405
- 注册: 2009-09-24
- 专业: 药物化学
扎那米韦
|
Title: Zanamivir CAS Registry Number: 139110-80-8 CAS Name: 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid Additional Names: 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid; 4-guanidino-Neu5Ac2en; 5-acetamido-4-guanidino-2,3,4,5-tetradeoxy-D-glycero-D-galacto-non-2-enopyranosonic acid Manufacturers' Codes: GG-167; GR-121167X Trademarks: Relenza (GSK) Molecular Formula: C12H20N4O7 Molecular Weight: 332.31 Percent Composition: C 43.37%, H 6.07%, N 16.86%, O 33.70% Literature References: Influenza viral neuraminidase inhibitor; structural analog of the sialic acids, q.v. Prepn: L. M. von Itzstein et al., WO 9116320; eidem, US 5360817 (1991, 1994 both to Biota); M. von Itzstein et al., Carbohydr. Res. 259, 301 (1994). Structure-activity study: eidem et al., Nature 363, 418 (1993). Inhibition of sialidase (neuraminidase) from influenza virus: M. S. Pegg, M. von Itzstein, Biochem. Mol. Biol. Int. 32, 851 (1994). In vitro antiviral activity: J. M. Woods et al., Antimicrob. Agents Chemother. 37, 1473 (1993). HPLC determn in serum: R. J. Stubbs, A. J. Harker, J. Chromatogr. B 670, 279 (1995). Clinical trial in influenza A and B infection: F. G. Hayden et al., N. Engl. J. Med. 337, 874 (1997); in prevention of influenza in healthy adults: A. S. Monto et al., J. Am. Med. Assoc. 282, 31 (1999). Properties: Colorless crystals as the sesquihydrate, mp 256° (dec). [a]D20 +40.9° (c = 0.9 in water). Zwitterionic at physiological pH. Melting point: mp 256° (dec) Optical Rotation: [a]D20 +40.9° (c = 0.9 in water) Therap-Cat: Antiviral. Keywords: Antiviral; Sialic Acid Analogs; Neuraminidase Inhibitor. |
7楼2009-12-08 15:53:08
20